Dan Lemaitre is Director at GLOBUS MEDICAL INC (GMED). They have made 7 open-market trades across 2 companies since 2017, most recently 2024-11-22.
CIK 0001478479
1 open-market purchase totalling $200K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GMED | SELL | 2024-11-21 | 2024-11-25 | $85.00 | $1.3M | -1.9% | -0.6% | -5.8% |
| GMED | SELL | 2024-05-10 | 2024-05-14 | $64.61 | $4.1M | +4.0% | +4.2% | +15.4% |
| GMED | SELL | 2023-05-15 | 2023-05-17 | $56.98 | $2.5M | -7.3% | +3.3% | +0.6% |
| GMED | SELL | 2021-03-09 | 2021-03-11 | $62.47 | $1.9M | -2.9% | +8.9% | +14.3% |
| ELGX | SELL | 2020-09-04 | 2020-09-17 | $0.05 | $3K | N/A | N/A | N/A |
| ELGX | SELL | 2020-08-13 | 2020-08-19 | $0.08 | $192 | N/A | N/A | N/A |
| ELGX | BUY | 2017-05-22 | 2017-05-23 | $4.43 | $200K | -2.5% | -1.0% | -12.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.